HER2/neu as a Predictive Factor in Breast Cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference50 articles.
1. ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase;Hellyer;Biochem J,1998
2. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin;Sliwkowski;J Biol Chem,1994
3. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989
4. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer;Van de Vijver;N Engl J Med,1988
5. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer;Allred;Hum Pathol,1992
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Investigating mutations at the hotspot position of the ERBB2 and screening for the novel lead compound to treat breast cancer – a computational approach;Advances in Protein Chemistry and Structural Biology;2021
2. HER2 somatic mutation analysis in breast cancer: correlation with clinicopathological features;Human Pathology;2019-10
3. Novel Human Bispecific Aptamer–Antibody Conjugates for Efficient Cancer Cell Killing;Cancers;2019-08-29
4. miR-328-5p inhibits MDA-MB-231 breast cancer cell proliferation by targeting RAGE;Oncology Reports;2018-04-04
5. Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response;Clinical Cancer Research;2017-11-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3